Immediate Impact
62 standout
Citing Papers
Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Xiaozhong Chen being referenced
436 A phase II study of AK104, a bispecific antibody targeting PD-1 and CTLA-4, in patients with metastatic nasopharyngeal carcinoma (NPC) who had progressed after two or more lines of chemotherapy
2021
Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xiaozhong Chen | 331 | 301 | 215 | 340 | 113 | 1.3k | |
| Matthias Hautmann | 172 | 309 | 234 | 243 | 69 | 1.0k | |
| Kazuki Hashimoto | 189 | 425 | 374 | 249 | 123 | 1.4k | |
| Shin‐ichi Yamada | 188 | 251 | 311 | 262 | 118 | 1.3k | |
| Shin‐ichi Yamada | 169 | 297 | 208 | 490 | 78 | 1.1k | |
| Lin Li | 106 | 365 | 217 | 357 | 142 | 1.5k | |
| Hiroshi Kajiwara | 31 | 363 | 336 | 350 | 128 | 1.7k | |
| Xia Deng | 86 | 156 | 160 | 524 | 62 | 1.2k | |
| Jean‐Baptiste Guy | 72 | 428 | 144 | 383 | 89 | 1.4k | |
| Zheng Yan | 26 | 550 | 313 | 495 | 101 | 1.4k | |
| Hong‐Gyun Wu | 284 | 312 | 332 | 205 | 100 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...